Back to Search Start Over

144P Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer (TD-NICE): A single arm, phase II study.

Authors :
Yan, X.
Zhao, J.
Lei, J.
Duan, H.
Ni, Y.
Zhou, Y.
Wang, X.
Qi, H.
Liu, H.
Tian, F.
Lu, Q.
Sun, J.
Yang, E.
Zhong, D.
Wang, T.
Huang, L.
Wang, J.
Jiang, T.
Source :
Annals of Oncology. 2021 Supplement 7, Vol. 32, pS1442-S1442. 1p.
Publication Year :
2021

Subjects

Subjects :
*NEOADJUVANT chemotherapy
*ESOPHAGEAL cancer

Details

Language :
English
ISSN :
09237534
Volume :
32
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
153829447
Full Text :
https://doi.org/10.1016/j.annonc.2021.10.163
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details